Clinical trial
Hemospray Effectiveness and Predictors of Rebleeding in Patients With Gastrointestinal Hemorrhage: A Real-life Multicenter Cohort.
NCT03611504 is registered in ClinicalTrials.gov with Hospital Universitario Ramon y Cajal as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hemospray Effectiveness and Predictors of Rebleeding in Patients With Gastrointestinal Hemorrhage: A Real-life Multicenter Cohort.
- Lead sponsor
- Hospital Universitario Ramon y Cajal
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 1, 2018
- Completion date
- December 30, 2018
- Enrollment
- 261 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gastrointestinal hemorrhage, tumor bleeding, ulcer hemorrhage